Healthcare News

AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce...

Development of quantitative biomarker strategies for proteopathies through seragy’s proprietary SeRAS® technologyExpansion of the company’s laboratory and analytical capabilities with funding from...

LONDON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd., a biotechnology company pioneering extracellular matrix (ECM)-based drug discovery and development in oncology, fibrosis and...

Synmosa to lead regulatory approvals, market access, distribution and sales in Singapore, Thailand, Indonesia, Malaysia, the Philippines, Vietnam, Australia and New Zealand.Nxera to supply drug...

Sapreme Therapeutics announces its lead Duchenne muscular dystrophy candidate, SPM-2551, and is presenting preclinical data at the OTS Annual Meeting.

ORION CORPORATION PRESS RELEASE 14 OCTOBER 2026 at 9.00 EEST         Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026         Orion will publish...

ORION OYJ        LEHDISTÖTIEDOTE        14.10.2026 KLO 9.00         Orion julkaisee osavuosikatsauksen 1–9/2026 ja järjestää verkkolähetyksen 28.10.2026 Orion julkaisee osavuosikatsauksen...

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026.

Phonak announces Roger On Sphere™, the world's first remote microphone powered by a DNN that separates speech from background noise in real time.

 -- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in...